HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia.

AbstractOBJECTIVE:
Hereditary spastic paraplegias (HSPs) comprise a heterogeneous group of neurodegenerative disorders resulting in progressive spasticity of the lower limbs. One form of autosomal recessive hereditary spastic paraplegia (ARHSP) with thin corpus callosum (TCC) was linked to chromosomal region 15q13-21 (SPG11) and associated with mutations in the spatacsin gene. We assessed the long-term course and the mutational spectrum of spatacsin-associated ARHSP with TCC.
METHODS:
Neurological examination, cerebral magnetic resonance imaging (MRI), 18fluorodeoxyglucose positron emission tomography (PET), nerve biopsy, linkage and mutation analysis are presented.
RESULTS:
Spastic paraplegia in patients with spatacsin mutations (n = 20) developed during the second decade of life. The Spastic Paraplegia Rating Scale (SPRS) showed severely compromised walking between the second and third decades of life (mean SPRS score, >30). Impaired cognitive function was associated with severe atrophy of the frontoparietal cortex, TCC, and bilateral periventricular white matter lesions. Progressive cortical and thalamic hypometabolism in the 18fluorodeoxyglucose PET was observed. Sural nerve biopsy showed a loss of unmyelinated nerve fibers and accumulation of intraaxonal pleomorphic membranous material. Mutational analysis of spatacsin demonstrated six novel and one previously reported frameshift mutation and two novel nonsense mutations. Furthermore, we report the first two splice mutations to be associated with SPG11.
INTERPRETATION:
We demonstrate that not only frameshift and nonsense mutations but also splice mutations result in SPG11. Mutations are distributed throughout the spatacsin gene and emerge as major cause for ARHSP with TCC associated with severe motor and cognitive impairment. The clinical phenotype and the ultrastructural analysis suggest a disturbed axonal transport of long projecting neurons.
AuthorsUte Hehr, Peter Bauer, Beate Winner, Rebecca Schule, Akguen Olmez, Wolfgang Koehler, Goekhan Uyanik, Anna Engel, Daniela Lenz, Andrea Seibel, Andreas Hehr, Sonja Ploetz, Josep Gamez, Arndt Rolfs, Joachim Weis, Thomas M Ringer, Michael Bonin, Gerhard Schuierer, Joerg Marienhagen, Ulrich Bogdahn, Bernhard H F Weber, Haluk Topaloglu, Ludger Schols, Olaf Riess, Juergen Winkler
JournalAnnals of neurology (Ann Neurol) Vol. 62 Issue 6 Pg. 656-65 (Dec 2007) ISSN: 1531-8249 [Electronic] United States
PMID18067136 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon, Nonsense
  • Proteins
  • SPG11 protein, human
Topics
  • Adult
  • Brain (pathology)
  • Cerebral Cortex (diagnostic imaging, metabolism)
  • Codon, Nonsense
  • Cognition
  • Corpus Callosum (pathology)
  • Female
  • Frameshift Mutation
  • Genes, Recessive
  • Humans
  • Longitudinal Studies
  • Mutation
  • Nerve Fibers, Unmyelinated (pathology)
  • Pedigree
  • Positron-Emission Tomography
  • Proteins (genetics)
  • Severity of Illness Index
  • Spastic Paraplegia, Hereditary (genetics, metabolism, physiopathology, psychology)
  • Sural Nerve (pathology)
  • Thalamus (diagnostic imaging, metabolism)
  • Walking

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: